RxDoctor Payments Data

Troy Davis, PA

Dermatology · Missoula, MTNPI 1790793685

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 93.3% of the total across 294 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 26 manufacturers, the largest accounting for just 13.8% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $2,124 and has fallen 66.6% since, to $710 in 2025.

$6,231in general payments, 2019–2025

Across 294 payments — averaging $21.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$862
  • Johnson & Johnson$750
  • Amgen$684
  • E.r. Squibb & Sons, L.L.C.$548
  • Novartis$525
  • Lilly USA, LLC$434
  • plus $2K from 20 others

What the payments were for

  • Food & beverage$5,81293%
  • Education$4197%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,231 in reported general payments places this provider in the 85th percentile of 46 dermatology providers in Montana.

See all dermatology providers in Montana

Medicare billing

Part B allowed, 2024
$234,317
Medicare patients
453
Services billed
2,548

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Imiquimod50$2,254
Clobetasol Propionate42$2,125
Ketoconazole31$553
Triamcinolone Acetonide21$328
Doxycycline Hyclate15$169
Terbinafine Hcl21$84

Paid to pharmacies, not to this prescriber.

Other dermatology in Missoula

See the full list for Montana

Where these figures come from

Is this you, or does something look wrong? →